Intrinsiqq
Greenwich LifeSciences Inc. logo

Greenwich LifeSciences Inc. Insider Trading

GLSI

Compare
Last 12 months

Insiders bought 476K on the open market and sold nothing.

Net open-market
+476K
9 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
1 / 0
executives and directors
Last open-market buy
Jul 2026
Jul 29, 2026

Get an email when GLSI's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Jul 28 – 29
    Snehal Patel
    CEO and CFO · bought 2,200 at avg $13.43
    30K
    <0.1% of stake
  • Jul 27
    Snehal Patel
    CEO and CFO · bought 1,500 at $13.62
    20K
    <0.1% of stake
  • Jul 23 – 24
    Snehal Patel
    CEO and CFO · bought 3,600 at avg $13.06
    47K
    <0.1% of stake
  • Jan 13
    Snehal Patel
    CEO and CFO · bought 1,800 at $29.83
    54K
    <0.1% of stake
  • Jan 12
    Snehal Patel
    CEO and CFO · bought 2,900 at $27.54
    80K
    <0.1% of stake
  • Dec 31, 2025
    Snehal Patel
    CEO and CFO · bought 4,300 at $21.36
    92K
    <0.1% of stake
  • Dec 30, 2025
    Snehal Patel
    CEO and CFO · bought 2,900 at $21.73
    63K
    <0.1% of stake
  • Dec 18, 2025
    Snehal Patel
    CEO and CFO · bought 4,100 at $12.62
    52K
    <0.1% of stake
  • Nov 25, 2025
    Snehal Patel
    CEO and CFO · bought 4,600 at $8.37
    39K
    <0.1% of stake
  • Nov 7, 2025
    Snehal Patel
    CEO and CFO · bought 10,600 at $8.43
    89K
    0.2% of stake
  • Oct 31, 2025
    Snehal Patel
    CEO and CFO · bought 2,300 at $9.26
    21K
    <0.1% of stake
  • Apr 25, 2025
    Snehal Patel
    CEO and CFO · bought 3,600 at $9.88
    36K
    <0.1% of stake
  • Apr 17, 2025
    Snehal Patel
    CEO and CFO · bought 5,400 at $8.98
    48K
    <0.1% of stake
  • Apr 7, 2025
    Snehal Patel
    CEO and CFO · bought 3,600 at $9.10
    33K
    <0.1% of stake
  • Apr 4, 2025
    Snehal Patel
    CEO and CFO · bought 5,500 at $8.73
    48K
    <0.1% of stake
  • Jan 10, 2025
    Snehal Patel
    CEO and CFO · bought 2,500 at $12.51
    31K
    <0.1% of stake
  • Jan 6, 2025 – Jan 7, 2025
    Snehal Patel
    CEO and CFO · bought 2,900 at avg $13.58
    39K
    <0.1% of stake
  • Jan 3, 2025
    Snehal Patel
    CEO and CFO · bought 3,400 at $12.95
    44K
    <0.1% of stake
  • Jan 2, 2025
    Snehal Patel
    CEO and CFO · bought 2,000 at $11.97
    24K
    <0.1% of stake
  • Dec 31, 2024
    Snehal Patel
    CEO and CFO · bought 2,400 at $11.36
    27K
    <0.1% of stake
  • Dec 30, 2024
    Snehal Patel
    CEO and CFO · bought 3,200 at $11.12
    36K
    <0.1% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch GLSI, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with GLSI

CompareIntrinsic value
AYTUAytu BioPharma Inc.
$2.66+0.00%34
OMEROmeros Corporation
$13.21-5.71%28
ENTAEnanta Pharmaceuticals Inc.
$7.62-4.51%25
SXTP60 Degrees Pharmaceuticals Inc.
$0.47-6.40%25
NXTSNexentis Technologies Inc.
$1.58-7.06%20
APVOAptevo Therapeutics Inc.
$0.40-2.39%20
HCWBHCW Biologics Inc.
$0.75+1.90%15
ALXOAlx Oncology Holdings Inc.
$1.07+4.41%10

Held by ETFs

GLSI is in 5 US ETFs. The largest of them, with GLSI's weight in each:

Spot a number that looks wrong? Check it in GLSI's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing GLSI

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.